The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...
A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; ...
The "Osteoporosis_Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an overview of Osteoporosis Clinical ...
J&J said it plans to “explore future development opportunities for aticaprant in other areas of high unmet need”. A statement ...
Secondary endpoint analyses from the trials showed 'significant improvements' in patients treated with the antibody.
Nanomerics Ltd. announced the successful completion of its OC134 Phase I trial - the SUNLIGHT trial. With the clinical phase competed the trial for OC134 and the MET platform has met its primary ...